Medtronic to Participate in the Piper Jaffray Post-EuroPCR Summit

May 18, 2009 -- Minneapolis -- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Piper Jaffray PCR Post-Op Summit on Friday, May 22, 2009, in London.

Scott Ward, President, CardioVascular Medtronic

Scott Ward, president of the CardioVascular business and senior vice president at Medtronic, will speak to the attendees of the conference at 8 a.m. British Summer Time (2 a.m. Central Daylight Time). Ward will provide remarks highlighting Medtronic’s activities and product news from the EuroPCR conference. A live audio webcast of the presentation will be available to all interested parties at Medtronic’s Investor Relations website at http://www.medtronic.com.

About Medtronic
Medtronic, Inc., headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

Source: Medtronic, Inc.

send comments & suggestions to "info at angioplasty dot org"
Read our Privacy statement.

Angioplasty.Org is an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY

For more information, see About Us
All content, including text, photos and video
© Copyright Venture Digital LLC 1996-2022